← Leaderboards
Gay Miriam Crooks
Children'S Hospital Los Angeles
$19,471,318
Attributed
$25,336,870
Total exposure
17
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,336,870 · 17
By mechanism
R01$8,814,538 · 6
T32$5,317,262 · 1
P01$4,658,388 · 3
U01$4,149,990 · 1
R21$863,500 · 2
P30$791,112 · 3
Top collaborators
- Owen N Witte12 shared
- Yi Xing6 shared
- Chintan Parekh3 shared
- David A. Nathanson2 shared
Most similar at Children'S Hospital Los Angeles
Same institution · by research overlap
- Kimberly J Payne$2,021,603
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsThymus GlandT-LymphocyteHematopoietic Stem CellsHematopoieticTissuesStem CellsAffectHuman TissueOrganoidsSourceBone MarrowPathway InteractionsProgramsCancer CellCancer TherapyGrowthProductionBlood VesselsMouse ModelBaseEventGaysMediating
Grant awards (62)
The role of BCL11B in T lineage fate during human thymopoiesis and pluripotent stem cell differentiation$818,621
R01 · FY2025 · AI · contact PI
The Role of lymphatic endothelium in the developing thymus$620,289
R01 · FY2025 · AI · contact PI
Tumor Cell Biology Training Program$412,722
T32 · FY2025 · CA · contact PI
Cancer and Stem Cell Biology (CSCB)$83,092
P30 · FY2025 · CA · contact PI
The role of BCL11B in T lineage fate during human thymopoiesis and pluripotent stem cell differentiation$818,795
R01 · FY2024 · AI · contact PI
The Role of lymphatic endothelium in the developing thymus$620,278
R01 · FY2024 · AI · contact PI
Tumor Cell Biology Training Program$486,665
T32 · FY2024 · CA · contact PI
Cancer and Stem Cell Biology$155,261
P30 · FY2024 · CA · contact PI
The role of BCL11B in T lineage fate during human thymopoiesis and pluripotent stem cell differentiation$845,988
R01 · FY2023 · AI · contact PI
The Role of lymphatic endothelium in the developing thymus$634,062
R01 · FY2023 · AI · contact PI
Tumor Cell Biology Training Program$480,906
T32 · FY2023 · CA · contact PI
Cancer and Stem Cell Biology$155,262
P30 · FY2023 · CA · contact PI
Targeting alternative splicing for TCR discovery in small cell carcinomas$779,998
U01 · FY2022 · CA
Cancer and Stem Cell Biology$155,262
P30 · FY2022 · CA · contact PI
Targeting alternative splicing for TCR discovery in small cell carcinomas$779,998
U01 · FY2021 · CA
Tumor Cell Biology Training Program$522,696
T32 · FY2021 · CA · contact PI
Targeting alternative splicing for TCR discovery in small cell carcinomas$250,000
U01 · FY2021 · CA
Cancer and Stem Cell Biology$155,262
P30 · FY2021 · CA · contact PI
Targeting alternative splicing for TCR discovery in small cell carcinomas$779,998
U01 · FY2020 · CA
Tumor Cell Biology Training Program$511,197
T32 · FY2020 · CA · contact PI
Discovery and manipulation of mesenchymal signals for thymic rejuvenation$407,992
R01 · FY2020 · AG · contact PI
Cancer and Stem Cell Biology$86,973
P30 · FY2020 · CA · contact PI
Targeting alternative splicing for TCR discovery in small cell carcinomas$779,998
U01 · FY2019 · CA
Tumor Cell Biology Training Program$470,139
T32 · FY2019 · CA · contact PI
Discovery and manipulation of mesenchymal signals for thymic rejuvenation$407,992
R01 · FY2019 · AG · contact PI
Targeting alternative splicing for TCR discovery in small cell carcinomas$779,998
U01 · FY2018 · CA
Tumor Cell Biology Training Program$432,898
T32 · FY2018 · CA · contact PI
Discovery and manipulation of mesenchymal signals for thymic rejuvenation$407,992
R01 · FY2018 · AG · contact PI
Discovery and manipulation of mesenchymal signals for thymic rejuvenation$407,992
R01 · FY2017 · AG · contact PI
Tumor Cell Biology Training Program$397,157
T32 · FY2017 · CA · contact PI
Tumor Cell Biology Training Program$436,100
T32 · FY2016 · CA · contact PI
Discovery and manipulation of mesenchymal signals for thymic rejuvenation$407,992
R01 · FY2016 · AG · contact PI
A novel thymic implant strategy to induce T cell reconstitution and immune tolerance for patients with complete DiGeorge Syndrome$192,500
R21 · FY2016 · AI · contact PI
Tumor Cell Biology Training Program$402,313
T32 · FY2015 · CA · contact PI
A novel thymic implant strategy to induce T cell reconstitution and immune tolerance for patients with complete DiGeorge Syndrome$231,000
R21 · FY2015 · AI · contact PI
Tumor Cell Biology Training Program$374,579
T32 · FY2014 · CA · contact PI
Tumor Cell Biology Training Program$389,890
T32 · FY2013 · CA · contact PI
Stem Cell Therapies for Primary Immune Deficiency$1,291,262
P01 · FY2010 · AI · contact PI
Stem Cell Therapies for Primary Immune Deficiency$1,275,602
P01 · FY2009 · AI · contact PI
Enhancing immune reconstitution after implantation of postnatal allogeneic thymus$200,000
R21 · FY2009 · HL · contact PI
Enhancing immune reconstitution after implantation of postnatal allogeneic thymus$174,499
R21 · FY2008 · HL · contact PI
Enhancing immune reconstitution after implantation of postnatal allogeneic thymus$65,501
R21 · FY2008 · HL · contact PI
Transplantation biology of human lymphoid progenitors$352,723
R01 · FY2007 · HL · contact PI
Transduction of Human Stem and Progenitor Cells$327,078
P01 · FY2007 · HL · contact PI
Core B--- Flow Cytometry/Histology$213,558
P01 · FY2007 · HL · contact PI
Transplantation biology of human lymphoid progenitors$363,258
R01 · FY2006 · HL · contact PI
Transduction of Human Stem and Progenitor Cells$321,993
P01 · FY2006 · HL · contact PI
Core B--- Flow Cytometry/Histology$210,281
P01 · FY2006 · HL · contact PI
Transplantation biology of human lymphoid progenitors$372,000
R01 · FY2005 · HL
Transduction of Human Stem and Progenitor Cells$312,612
P01 · FY2005 · HL
Cell cycle ontrol of B-cell mass$228,450
R01 · FY2005 · DK
Core B--- Flow Cytometry/Histology$204,198
P01 · FY2005 · HL
Transplantation biology of human lymphoid progenitors$372,000
R01 · FY2004 · HL
Transduction of Human Stem and Progenitor Cells$303,509
P01 · FY2004 · HL
Cell cycle control of B-cell mass$228,450
R01 · FY2004 · DK
Core B--- Flow Cytometry/Histology$198,295
P01 · FY2004 · HL
REGULATION OF LYMPHOPOIESIS FROM PLURIPOTENT STEM CELLS$185,520
P50 · FY2002 · HL
TRANSDUCTION OF HUMAN HEMATOPOIETIC STEM CELLS$252,256
R01 · FY2001 · DK
REGULATION OF LYMPHOPOIESIS FROM PLURIPOTENT STEM CELLS$185,520
P50 · FY2001 · HL
REGULATION OF LYMPHOPOIESIS FROM PLURIPOTENT STEM CELLS$185,520
P50 · FY2001 · HL
TRANSDUCTION OF HUMAN HEMATOPOIETIC STEM CELLS$247,408
R01 · FY2000 · DK
REGULATION OF LYMPHOPOIESIS FROM PLURIPOTENT STEM CELLS$185,520
P50 · FY2000 · HL